Table 1.
Clinicopathological characteristics | Number (n=69) | Percent (%) | CDK12 | p-value | ||
---|---|---|---|---|---|---|
Low (n=34) | High (n=35) | |||||
Age | Median (range) | 64 (30-86) | 60.5±10.72 | 69±10.73 | 0.0149(*) | |
Gender | Male | 55 | 79.7 | 28 (82.4) | 27 (77.1) | 0.8535 |
Female | 14 | 20.3 | 6 (17.6) | 8 (22.9) | ||
Pathology grade | Ⅱ | 23 | 33.3 | 8 (23.5) | 15 (42.9) | 0.1622 |
Ⅱ-Ⅲ | 22 | 31.9 | 11 (32.4) | 11 (31.4) | ||
Ⅲ | 24 | 34.8 | 15 (44.1) | 9 (25.7) | ||
Clinical stage | 1 | 4 | 5.9 | 1 (3.0) | 3 (8.6) | 0.7083 |
2 | 17 | 24.6 | 8 (23.5) | 9 (25.7) | ||
3 | 41 | 59.4 | 20 (58.8) | 21 (60.0) | ||
4 | 7 | 10.1 | 5 (14.7) | 2 (5.7) | ||
Pathomorphology | Ulcerative type | 61 | 88.4 | 30 (88.2) | 31 (88.6) | 0.3345 |
Protrude type | 7 | 10.1 | 3 (8.8) | 4 (11.4) | ||
Infiltrating type | 1 | 1.5 | 1 (3.0) | 0 (0.0) | ||
Tumor size(mm3) | Median (range) | 19.29 (3-234) | 19.54±41.11 | 18±31.22 | 0.4460 | |
Lymph node | Median (range) | 25 (8-71) | 24.5±11.27 | 27±7.24 | 0.2346 | |
Positive lymph node | Median (range) | 3 (0-42) | 4±10.60 | 3±5.49 | 0.0869 |